Saint John's Cancer Institute
Saint John’s Cancer Institute is a prominent research and treatment facility known for its cutting-edge therapeutics, translational science and exemplary cancer care.
Give NowThe Institute boasts a rich history of pioneering advancements in cancer treatment. It was the first in California to adopt the NanoKnife prostate cancer technique, introducing a less invasive option for patients. The Institute also leads the way in offering novel treatments for bladder, kidney, and prostate cancer, continually pushing the boundaries of medical science.
Formerly known as the John Wayne Cancer Institute, the Institute upholds the legacy of its founder, Dr. Donald L. Morton. Together with Dr. Armando Guiliano, Dr. Morton pioneered the Sentinel Lymph Node Biopsy, which has become the standard of lymph node care for melanoma and breast cancer worldwide.
But cancer care is not precise, and treatment often requires multiple approaches to find the most effective therapy for each patient. Saint John’s Cancer Institute leverages cutting-edge developments in genomics, artificial intelligence, and other emerging technologies to refine and personalize cancer care. Furthermore, the Institute’s commitment to robust fellowship programs, extensive clinical trials, and bold collaborative research ensures continuous progress in the fight against cancer.
“I’m amazed at how many people have been impacted in the last 50 years by some of these exciting trials that all took place at Saint John’s. Trials that could never have happened without Foundation support.”
Anton Bilchik, MD, PhD
Executive Medical Director,
Saint John’s Cancer Institute
Support Saint John's Cancer Institute
To learn more about giving opportunities, contact Sue Mathews, Director of Philanthropy, at sue.mathews@providence.org or call 310.829.8394.
Your Impact
Philanthropy is essential for sustaining Saint John’s Cancer Institute as a leader in cancer treatment, while facilitating the breakthroughs that will ultimately make cancer completely treatable and curable.
Funding plays a crucial role in empowering clinician-researchers at Saint John’s Cancer Institute to maximize the potential of its pioneering biorepository lab. Philanthropy supports translational cancer research, helps expand immunotherapy investigation of solid tumors, and maintains an unwavering commitment to innovation and excellence. Investment enables the Institute to broaden its specialized training programs, such as the Surgical Oncology Fellowship Program, which, since its inception in 1991, has successfully trained over 170 fellows.
Additionally, funding will facilitate the expansion of genomics research, clinical trials, and a new cellular therapy program that will be important to Saint John’s overall options for care and research. Philanthropy will also help advance artificial intelligence, machine learning, and the pursuit of other novel and emerging technologies with the potential to revolutionize cancer care and treatment.
News & Stories
When Jenny Braun needed a new approach to cancer treatment as she battled her third bout with the disease, her firefighter son recommended Saint John’s. There she found a higher standard of communication, innovative and personalized care and a renewed confidence. “The camaraderie and the professionalism of the doctors working together to come up with the best care for me personally, I’ve never had that before,” Jenny said. “They’re just very committed to the best possible patient care and that, to me, has been wonderful.”
